Announcements Trials
Browse Landscape

Phase

Phase 4 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Pancreatic Neoplasms 2Carcinoma, Hepatocellular 2Stomach Neoplasms 1Pulmonary Embolism 1Gastrointestinal Stromal Tumors 1Gallbladder Neoplasms 1Fibrosis 1Esophageal Neoplasms 1Duodenal Neoplasms 1Cholangiocarcinoma 1Biliary Tract Neoplasms 1

Interventions

Blood Specimen Collection 6Magnetic Resonance Spectroscopy 4Tenofovir 3Liver Transplantation 3Specimen Handling 2Sorafenib 2Simvastatin 2tremelimumab 1sonidegib 1sofosbuvir-velpatasvir drug combination 1peginterferon alfa-2a 1navitoclax 1maltodextrin 1hepatitis B hyperimmune globulin 1durvalumab 1contrast agent BR1 1bavituximab 1atezolizumab 1apixaban 1adefovir dipivoxil 1Viusid 1Vitamin D 1User-Centered Design 1Surveys and Questionnaires 1Sunitinib 1Spermine Synthase 1Sonazoid 1Sampling Studies 1Radiotherapy 1Radiofrequency Ablation 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Fibrosis × apixaban × Gastrointestinal × Clear all
NCT07132515 2025-08-20

Efficacy & Safety of Anticoagulants in Cirrhosis ± HCC

Mansoura University

Phase 4 Recruiting
100 enrolled
Gastrointestinal

Fibrosis, Carcinoma, Hepatocellular

Data powered by HemOnc (CC BY 4.0) Colophon âš¡